학술논문

Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.
Document Type
journal article
Source
Future Oncology; Mar2020, Vol. 16 Issue 7, p263-268, 6p
Subject
VOMITING prevention
TUMOR diagnosis
TUMOR treatment
THERAPEUTIC use of antineoplastic agents
NAUSEA
INTRAVENOUS therapy
TIME
RETROSPECTIVE studies
ANTINEOPLASTIC agents
VOMITING
TREATMENT effectiveness
TUMORS
ANTIEMETICS
DISEASE complications
Language
ISSN
14796694
Abstract
Copyright of Future Oncology is the property of Future Medicine Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)